Drug profile · INN
masoprocol
ACTINEX
masoprocol (ACTINEX) is a insulin-like growth factor i receptor inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — masoprocol
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
masoprocol (ACTINEX) is a insulin-like growth factor i receptor inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Insulin-like growth factor I receptor inhibitor
Primary target: Insulin-like growth factor 1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is masoprocol?
masoprocol (ACTINEX) is a insulin-like growth factor i receptor inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for masoprocol?
ACTINEX is a marketed brand name for masoprocol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of masoprocol?
masoprocol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.